Clinical trial
STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
NCT06358469 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
- Lead sponsor
- Canadian Cancer Trials Group
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 10, 2024
- Completion date
- November 30, 2031
- Enrollment
- 249 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
vulvar squamous cell carcinoma